Altimmune, Inc.
ALT
$2.91
-$0.02-0.68%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -91.08M | -88.09M | -83.92M | -87.75M | -90.24M |
| Total Depreciation and Amortization | 106.00K | 112.00K | 119.00K | 129.00K | 160.00K |
| Total Amortization of Deferred Charges | 0.00 | 0.00 | 171.00K | 58.00K | -- |
| Total Other Non-Cash Items | 13.97M | 13.01M | 10.99M | 9.64M | 10.45M |
| Change in Net Operating Assets | 5.37M | 7.43M | 6.28M | -3.65M | -704.00K |
| Cash from Operations | -71.64M | -67.54M | -66.35M | -81.57M | -80.33M |
| Capital Expenditure | -32.00K | -11.00K | -10.00K | -10.00K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -131.03M | -132.46M | -39.67M | 110.85M | 6.03M |
| Cash from Investing | -131.06M | -132.47M | -39.68M | 110.84M | 6.03M |
| Total Debt Issued | 35.00M | 35.00M | 15.00M | 15.00M | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 218.40M | 174.06M | 122.50M | 83.10M | 45.47M |
| Repurchase of Common Stock | -726.00K | -709.00K | -686.00K | -690.00K | -928.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.48M | -1.51M | -1.02M | -698.00K | -121.00K |
| Cash from Financing | 251.20M | 206.84M | 135.80M | 96.71M | 44.42M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 48.50M | 6.83M | 29.76M | 125.98M | -29.87M |